Nav: Home

Leading cancer research organizations to host international cancer immunotherapy conference

August 03, 2015

NEW YORK - The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept. 16-19, 2015.

Titled "Translating Science into Survival," the meeting will cover all areas of inquiry in cancer immunology and immunotherapy, including: immune regulation of T-cell responsiveness, genomic methods for identifying tumor antigens, the tumor microenvironment, T-cell therapies, checkpoint blockade, biomarkers, combinations, and the microbiome. More than 60 talks by acknowledged leaders in these areas will be given.

The full program is available here: http://www.aacr.org/Meetings/Pages/Program-Detail.aspx?EventItemID=54&ItemID=149.

Registration is complimentary for credentialed news media. Members of the media can register using this form: http://www.aacr.org/Documents/15Immuno_RegForm.pdf. Return completed forms to Lauren Riley via email at lauren.riley@aacr.org or via fax at 215-446-7291.

Public information officers at medical institutes and cancer centers can also register by contacting Lauren Riley at lauren.riley@aacr.org or 215-446-7155.

Those following on social media can join the conversation on Twitter at #cicon15.
-end-
For more information, contact Julia Gunther at julia.gunther@aacr.org or 267-250-5441, or Jeff Molter at jeff.molter@aacr.org or 267-210-3965.

American Association for Cancer Research

Related Immunotherapy Articles:

Barrier Proteins in Tumors are Possible Key to Immunotherapy Success
By comparing variations in protein expression in tumor samples from a single melanoma patient, researchers from the Johns Hopkins Bloomberg~Kimmel Institute and the Memorial Sloan-Kettering Cancer Center say their findings have the potential to reveal some of the mechanisms underlying response or resistance to immunotherapy drugs.
Discovery could guide immunotherapy for lung cancer
Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment, according to a Cancer Research UK funded study* published today (Monday) in Nature Immunotherapy.
Genetic mutations predict patient response to immunotherapy
Results of a new clinical study establish particular genetic defects in tumors as clinical indicators for successful response to a type of immunotherapy called PD-1 blockade.
'Immunoswitch' particles may be key to more-effective cancer immunotherapy
Scientists at Johns Hopkins have created a nanoparticle that carries two different antibodies capable of simultaneously switching off cancer cells' defensive properties while switching on a robust anticancer immune response in mice.
Early research suggests first immunotherapy for mesothelioma on the horizon
Malignant pleural mesothelioma or MPM is a rare cancer, but its incidence has been rising.
A new T-cell population for cancer immunotherapy
Scientists at the University of Basel in Switzerland have, for the first time, described a new T cell population that can recognize and kill tumor cells.
Immunotherapy target suppresses pain to mask cancer
Duke University researchers found that a molecule called PD-L1, which is blocked by the immunotherapy drug nivolumab, acts not only on immune cells but also on the nerve cells that signal pain.
Immunotherapy against bee stings in some cases incomplete
The preparations that are used for allergen immunotherapy against bee sting allergies do not always contain all the relevant venom components.
New imaging method may predict immunotherapy response early
A noninvasive PET imaging method that measures granzyme B, a protein released by immune cells to kill cancer cells, was able to distinguish mouse and human tumors that responded to immune checkpoint inhibitors from those that did not respond early in the course of treatment.
T cell revival correlates with lung cancer response to PD-1 immunotherapy
In lung cancer patients who were taking immunotherapy drugs targeting the PD-1 pathway, testing for CD8 T cell activation in their blood partially predicted whether their tumors would shrink.

Related Immunotherapy Reading:

Cancer Immunotherapy Principles and Practice
by Lisa H. Butterfield PhD (Editor), Howard L. Kaufman MD FACS (Editor), Francesco M. Marincola MD FACS (Editor)

A Cure Within: Scientists Unleashing The Immune System to Kill Cancer
by Neil Canavan (Author)

Cancer Chemotherapy, Immunotherapy and Biotherapy
by Bruce A. Chabner MD (Author), Dan L. Longo MD (Author)

The Basics of Cancer Immunotherapy
by Haidong Dong (Editor), Svetomir N. Markovic (Editor)

Curing Cancer with Immunotherapy: How it happened a century ago, what we learned as we attempted it, and why it is possible today.
by Rene Chee (Author), Edward Chee (Author)

Immunotherapy (Advances in Experimental Medicine and Biology)
by Aung Naing (Editor), Joud Hajjar (Editor)

Cancer Immunotherapy: Immune Suppression and Tumor Growth
by George C. Prendergast (Editor), Elizabeth M. Jaffee (Editor)

Immunopatient: The New Frontier of Curing Cancer
by Peter Rooney (Author)

Handbook of Targeted Cancer Therapy and Immunotherapy
by Daniel D. Karp (Editor), Gerald S. Falchook MD MS (Editor), Joann Lim (Editor)

Immunotherapy of Cancer: An Innovative Treatment Comes of Age
by Yoshiyuki Yamaguchi (Editor)

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

The Story Behind The Numbers
Is life today better than ever before? Does the data bear that out? This hour, TED speakers explore the stories we tell with numbers — and whether those stories portray the full picture. Guests include psychologist Steven Pinker, economists Tyler Cowen and Michael Green, journalist Hanna Rosin, and environmental activist Paul Gilding.
Now Playing: Science for the People

#487 Knitting in PEARL
This week we're discussing math and things made from yarn. We welcome mathematician Daina Taimina to the show to discuss her book "Crocheting Adventures with Hyperbolic Planes: Tactile Mathematics, Art and Craft for all to Explore", and how making geometric models that people can play with helps teach math. And we speak with research scientist Janelle Shane about her hobby of training neural networks to do things like name colours, come up with Halloween costume ideas, and generate knitting patterns: often with hilarious results. Related links: Crocheting the Hyperbolic Plane by Daina Taimina and David Henderson Daina's Hyperbolic Crochet blog...